HOME /

Publications

Search
[ Author(Desc)] Title Type Year
A
Abdelmoneim AS, Eurich DT, Gamble JM, Johnson JA, Seubert JM, Qiu W, et al. Diabetes, Obesity and Metabolism. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: A nested case-control study [Internet]. 2014;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84890569821&partnerID=MN8TOARS
Abdelmoneim AS, Eurich DT, Gamble J-M, Simpson SH. Canadian Journal of Diabetes. Use patterns of antidiabetic regimens by patients with type2 diabetes [Internet]. 2013;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84889564451&partnerID=MN8TOARS
Abu-Ashour W, Twells LK, Valcour JE, Gamble J-M. BMC Infectious Diseases. Diabetes and the occurrence of infection in primary care: A matched cohort study [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85041391565&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: a Canadian cross-sectional study [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Abu-Ashour W, Twells L, Valcour J, Randell A, Donnan J, Howse P, et al. BMJ Open Diabetes Research and Care. The association between diabetes mellitus and incident infections: A systematic review and meta-analysis of observational studies [Internet]. 2017;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85020049309&partnerID=MN8TOARS
Abu-Ashour W, Chibrikova L, Midodzi WK, Twells LK, Gamble J-M. Diabetic Medicine. Factors associated with early insulin initiation in Type 2 diabetes: A Canadian cross-sectional study [Internet]. 2016;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-84959105986&partnerID=MN8TOARS
Alkabbani W, Maxwell CJ, Marrie RAnn, Tyas SL, Lega IC, Gamble J‐M. Diabetes, Obesity and Metabolism. Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities [Internet]. 2024;Available from: https://doi.org/10.1111/dom.15385
Alkabbani W, Gamble J-M. British Journal of Clinical Pharmacology. Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85124712639&partnerID=MN8TOARS
Alkabbani W, Gamble J-M. Canadian Journal of Diabetes. Prescribing Trends of the Sodium–Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015–2021) [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85143981743&partnerID=MN8TOARS
Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. Diabetes Care. Insulin Use in Type 2 Diabetes and the Risk of Dementia: A Comparative Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85165521395&partnerID=MN8TOARS
Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. Diabetes Care. Associations of Mid-and Late-Life Severe Hypoglycemic Episodes With Incident Dementia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147047452&partnerID=MN8TOARS
Alkabbani W, Shah BR, Zongo A, Eurich DT, Alsabbagh MW, Gamble J-M. Diabetes, Obesity and Metabolism. Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85167588605&partnerID=MN8TOARS
Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble J-M. International Journal of Epidemiology. Hypoglycaemia and the risk of dementia: a population-based cohort study using exposure density sampling [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85147424628&partnerID=MN8TOARS
Alkabbani W, Gamble J-M. Journal of Pharmaceutical Health Services Research. Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada [Internet]. 2023;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85163707017&partnerID=MN8TOARS
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Canadian Journal of Diabetes. Sodium-Glucose Cotransporter-2 Inhibitors and Urinary Tract Infections: A Propensity Score–matched Population-based Cohort Study [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129507933&partnerID=MN8TOARS
Alkabbani W, Gamble J-M, Eurich DT, Minhas-Sandhu JK, Shah BR, Alsabbagh MW, et al. Diabetes and Metabolism. Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85120915534&partnerID=MN8TOARS
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MW, et al. Diabetic Medicine. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85129462097&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug Safety. Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data [Internet]. 2022;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85125655701&partnerID=MN8TOARS
Alkabbani W, Pelletier R, Beazely MA, Labib Y, Quan B, Gamble J-M. Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data. DRUG SAFETY. 2022;45:287-295.
Alkabbani W, Zongo A, Minhas-Sandhu JK, Eurich DT, Shah BR, Alsabbagh MWasem, et al. Five comparative cohorts to assess the risk of genital tract infections associated with sodium-glucose cotransporter-2 inhibitors initiation in type 2 diabetes mellitus. DIABETIC MEDICINE. 2022;39:e14858.

Pages